ELOX logo

Eloxx Pharmaceuticals (ELOX) Accounts Payable

Annual Accounts Payable

$3.02 M
+$1.64 M+119.00%

December 31, 2022


Summary


Performance

ELOX Accounts Payable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherELOXbalance sheetmetrics:

Quarterly Accounts Payable

$3.13 M
+$13.00 K+0.42%

September 30, 2023


Summary


Performance

ELOX Quarterly Accounts Payable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherELOXbalance sheetmetrics:

Accounts Payable Formula

Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers

ELOX Accounts Payable Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+119.0%+96.5%
3 y3 years+61.4%+391.2%
5 y5 years+97.4%+319.5%

ELOX Accounts Payable Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+119.0%at high+127.3%
5 y5-yearat high+527.9%at high+551.6%
alltimeall timeat high>+9999.0%at high>+9999.0%

Eloxx Pharmaceuticals Accounts Payable History

DateAnnualQuarterly
Sep 2023
-
$3.13 M(+0.4%)
Jun 2023
-
$3.12 M(+28.2%)
Mar 2023
-
$2.43 M(-19.4%)
Dec 2022
$3.02 M(+119.0%)
$3.02 M(+89.3%)
Sep 2022
-
$1.59 M(-17.5%)
Jun 2022
-
$1.93 M(-33.4%)
Mar 2022
-
$2.90 M(+110.5%)
Dec 2021
$1.38 M(+186.7%)
$1.38 M(-45.0%)
Sep 2021
-
$2.51 M(+24.0%)
Jun 2021
-
$2.02 M(+317.3%)
Mar 2021
-
$485.00 K(+0.8%)
Dec 2020
$481.00 K(-74.3%)
$481.00 K(-24.6%)
Sep 2020
-
$638.00 K(-17.1%)
Jun 2020
-
$770.00 K(-44.6%)
Mar 2020
-
$1.39 M(-25.8%)
Dec 2019
$1.87 M(+150.5%)
$1.87 M(+10.9%)
Sep 2019
-
$1.69 M(-31.8%)
Jun 2019
-
$2.47 M(+10.4%)
Mar 2019
-
$2.24 M(+199.9%)
Dec 2018
$747.00 K(-51.2%)
$747.00 K(-44.7%)
Sep 2018
-
$1.35 M(-35.6%)
Jun 2018
-
$2.10 M(-3.5%)
Mar 2018
-
$2.17 M(+1900.9%)
Dec 2017
$1.53 M(+698.5%)
-
Sep 2017
-
$108.60 K(-43.3%)
Jun 2017
-
$191.60 K(+75.6%)
Jun 2017
$191.60 K(+112.2%)
-
Mar 2017
-
$109.10 K(-43.7%)
Dec 2016
-
$193.90 K(+33.8%)
Sep 2016
-
$144.90 K(+60.5%)
Jun 2016
$90.30 K(-61.1%)
$90.30 K(+59.5%)
Mar 2016
-
$56.60 K(-10.9%)
Dec 2015
-
$63.50 K(-63.6%)
Sep 2015
-
$174.40 K(-24.8%)
Jun 2015
$232.00 K(-74.3%)
$232.00 K(-64.7%)
Mar 2015
-
$656.50 K(-49.7%)
Dec 2014
-
$1.31 M(+112.9%)
Sep 2014
-
$613.00 K(-32.0%)
Jun 2014
$901.20 K(+41.4%)
$901.20 K(+177.4%)
Mar 2014
-
$324.90 K(-32.0%)
Dec 2013
-
$477.60 K(-52.4%)
Sep 2013
-
$1.00 M(+57.5%)
Jun 2013
$637.30 K(+7.2%)
$637.30 K(-7.2%)
Mar 2013
-
$686.90 K(-36.7%)
Dec 2012
-
$1.09 M(+16.5%)
Sep 2012
-
$932.20 K(+56.8%)
Jun 2012
$594.50 K(+6.3%)
$594.50 K(-26.1%)
Mar 2012
-
$804.80 K(+81.3%)
Dec 2011
-
$443.80 K(-53.2%)
Sep 2011
-
$949.10 K(+69.6%)
DateAnnualQuarterly
Jun 2011
$559.50 K(+0.4%)
$559.50 K(+9.6%)
Mar 2011
-
$510.30 K(-18.5%)
Dec 2010
-
$626.00 K(+26.6%)
Sep 2010
-
$494.40 K(-11.3%)
Jun 2010
$557.40 K(-42.9%)
$557.40 K(-60.2%)
Mar 2010
-
$1.40 M(+40.4%)
Dec 2009
-
$998.20 K(+134.3%)
Sep 2009
-
$426.10 K(-56.4%)
Jun 2009
$976.70 K(+163.8%)
$976.70 K(+106.8%)
Mar 2009
-
$472.40 K(+0.9%)
Dec 2008
-
$468.30 K(-6.3%)
Sep 2008
-
$499.90 K(+35.0%)
Jun 2008
$370.20 K(+238.7%)
$370.20 K(+119.7%)
Mar 2008
-
$168.50 K(-69.5%)
Dec 2007
-
$552.00 K(+80.5%)
Sep 2007
-
$305.80 K(+179.8%)
Jun 2007
$109.30 K(+40.7%)
$109.30 K(+24.9%)
Mar 2007
-
$87.50 K(-33.0%)
Dec 2006
-
$130.60 K(+23.7%)
Sep 2006
-
$105.60 K(+35.9%)
Jun 2006
$77.70 K(-64.3%)
$77.70 K(-47.9%)
Mar 2006
-
$149.10 K(+48.7%)
Dec 2005
-
$100.30 K(-28.2%)
Sep 2005
-
$139.60 K(-35.8%)
Jun 2005
$217.60 K(+215.4%)
$217.60 K(+98.5%)
Mar 2005
-
$109.60 K(+19.4%)
Dec 2004
-
$91.80 K(-38.3%)
Sep 2004
-
$148.90 K(+115.8%)
Jun 2004
$69.00 K(+23.0%)
$69.00 K(+178.2%)
Mar 2004
-
$24.80 K(-8.1%)
Dec 2003
-
$27.00 K(-20.8%)
Sep 2003
-
$34.10 K(-39.2%)
Jun 2003
$56.10 K(-30.0%)
$56.10 K(-9.7%)
Mar 2003
-
$62.10 K(+30.7%)
Dec 2002
-
$47.50 K(-81.3%)
Sep 2002
-
$253.40 K(+216.0%)
Jun 2002
$80.20 K(-52.5%)
$80.20 K(-1.4%)
Mar 2002
-
$81.30 K(+223.9%)
Dec 2001
-
$25.10 K(-80.6%)
Sep 2001
-
$129.30 K(-23.4%)
Jun 2001
$168.90 K(-21.3%)
$168.90 K(-1.2%)
Mar 2001
-
$171.00 K(+33.1%)
Dec 2000
-
$128.50 K(+40.3%)
Sep 2000
-
$91.60 K(-57.3%)
Jun 2000
$214.70 K(+26.5%)
$214.70 K(-9.1%)
Mar 2000
-
$236.20 K(+18.1%)
Dec 1999
-
$200.00 K
Jun 1999
$169.70 K(+5374.2%)
-
Jun 1998
$3100.00(-11.4%)
-
Jun 1997
$3500.00
-

FAQ

  • What is Eloxx Pharmaceuticals annual accounts payable?
  • What is the all time high annual accounts payable for Eloxx Pharmaceuticals?
  • What is Eloxx Pharmaceuticals annual accounts payable year-on-year change?
  • What is Eloxx Pharmaceuticals quarterly accounts payable?
  • What is the all time high quarterly accounts payable for Eloxx Pharmaceuticals?
  • What is Eloxx Pharmaceuticals quarterly accounts payable year-on-year change?

What is Eloxx Pharmaceuticals annual accounts payable?

The current annual accounts payable of ELOX is $3.02 M

What is the all time high annual accounts payable for Eloxx Pharmaceuticals?

Eloxx Pharmaceuticals all-time high annual accounts payable is $3.02 M

What is Eloxx Pharmaceuticals annual accounts payable year-on-year change?

Over the past year, ELOX annual accounts payable has changed by +$1.64 M (+119.00%)

What is Eloxx Pharmaceuticals quarterly accounts payable?

The current quarterly accounts payable of ELOX is $3.13 M

What is the all time high quarterly accounts payable for Eloxx Pharmaceuticals?

Eloxx Pharmaceuticals all-time high quarterly accounts payable is $3.13 M

What is Eloxx Pharmaceuticals quarterly accounts payable year-on-year change?

Over the past year, ELOX quarterly accounts payable has changed by +$1.54 M (+96.49%)